MFDS — authorised 4 June 1986
- Marketing authorisation holder: SCHERING
- Status: likely_approved
🇰🇷 Intron A in South Korea
MFDS authorised Intron A on 4 June 1986
Marketing authorisation
Intron A in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Intron A approved in South Korea?
Yes. MFDS authorised it on 4 June 1986.
Who is the marketing authorisation holder for Intron A in South Korea?
SCHERING holds the South Korean marketing authorisation.